Protection of Exogenous Phosphocreatine for Myocardium in Percutaneous Coronary Intervention Related to Inflammation.
Ling MY, Song YP, Liu C, Wang ZH, Wang Y, Li XH, Zhang Z, Zhou RX, Qie LY, Li M, Xiao YL, Chen HQ, Xing YQ.
Ling MY, et al. Among authors: wang zh, wang y.
Rev Cardiovasc Med. 2022 Mar 9;23(3):89. doi: 10.31083/j.rcm2303089.
Rev Cardiovasc Med. 2022.
PMID: 35345256
Free article.
Clinical Trial.